1. Вишневский В.А. и др. Современные принципы техники оперативных вмешательств на печени. Анналы хир. гепатол. 1996; 1: 15–23.
2. Скипенко О.Г. и др. Проблемы гемостаза и герметизма при резекциях печени с использованием фибрин-коллагеновой субстанции. Хирургия. 2003; 9: 18–23.
3. Скипенко О.Г. и др. Резекция печени: ближайшие результаты 132 операций. Анналы хир. гепатол. 2006; 11 (4): 28–37.
4. Федоров В.Д. и др. Основные осложнения обширных резекций печени и пути их предупреждения. Бюл. сиб. мед. 2007; 3: 16–21.
5. Adam R et al. Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases. Analysis of 1452 Patients and Development of a Prognostic Model. Ann Surg 2006; 244 (4): 524–35.
6. Alkozai EM et al. Bleeding in liver surgery: prevention and treatment. Clin Liver Dis 2009; 13: 145–54.
7. Asahara T et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 1999; 23: 676–80.
8. Berrevoet F et al. Use of topical hemostatic agents during liver resection. Dig Surg 2007; 24: 288–93.
9. Birth M et al. Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study. Pat Saf Surg 2009; 3: 13.
10. Boonstra EA et al. Topical haemostatic agents in liver surgery: do we need them? HPB 2009; 11: 306–10.
11. Carbon RT et al. Tissue management with fleece-bound sealing: materials, material science and clinical implementation. 6th World Congress of Trauma, Shock, Inflammation and Sepsis, 2–6 March 2004.
12. Chapman WC et al. Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma. Results of a randomized controlled trial. Arch Surg 2001; 1200–4.
13. Capussotti L et al. Bile leakage and liver resection. Where is the risk? Arch Surg 2006; 141: 690–4.
14. Dickneite G et al. A comparison of fibrin sealants in relation to their in vitro and in vivo properties. Thromb Res 2003; 112: 73–82.
15. Erdogan D et al. Prevention of biliary leakage after partial liver resection using topical hemostatic agents. Dig Surg 2007; 24: 294–9.
16. Erdogan D et al. Adhesive strength of fibrinogen-coated collagen patch or liquid fibrin sealant in an experimental liver resection model in pigs. Eur Surg Res 2008; 41: 298–302.
17. Figueras J et al. Application of fibrin glue sealant after hepatectomy does not seem justified. Results of randomized study in 300 patients. Ann Surg 2007; 245: 536–42.
18. Frilling A et al. Effectiveness of new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomized prospective trial. Langenbecks Arch Surg 2005; 390: 114–20.
19. Fong Y et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. 1001 consecutive cases. Ann Surg 1999; 230 (3): 309–21.
20. Jarnagin WR et al. Improvement in perioperative outcome after hepatic resection. Analysis of 1803 consecutive cases over the past decade. Ann Surg 2002; 4: 397–407.
21. Jaeck D et al. Longterm survival following resection of colorectal hepatic metastases: Association Francaise de Chirurgie. Br J Surg 1997; 84: 977–80.
22. Kooby D et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 2003; 237: 860–70.
23. Kraus WT et al. Scientific evidence for application of topical hemostats, tissue glues and sealants in hepatobiliary surgery. Am Col Surg 2005; 200 (3): 418–27.
24. Lam CM, Lo CM, Liu CL, Fan S. Biliary Complications during Liver Resection. W J Surg 2001; 25 (10): 1273–6.
25. Martin NE et al. Fibrin sealant for retinoblastoma: where are we? J Ocul Pharmacol Ther 2008; 24 (5): 433–8.
26. Meijer C et al. Coagulopathy following major liver resection: the effect of BPI and role of decreased synthesis of regulating proteins by the liver. Shock 2001; 15: 261–71.
27. Mullen JT et al. Hepatic insufficiency and mortality in 1059 noncirrhotic patient undergoing major hepatectomy. J Am Coll Surg. 2007; 204 (5): 854–62.
28. Nagano Y et al. Risk factors and management of bile leakage after hepatic resection. World J Surg 2003; 27: 695–8.
29. Nagino М et al. Complications of Hepatectomy for Hilar Cholangiocarcinoma. W J Surg 2001; 25 (10): 1277–83.
30. Nakajima Y et al. Control of intraoperative bleeding during liver resection. Analysis of a questionaire sent to 231 Japanese hospitals. Surg Today 2002; 32: 48–52.
31. Noun R et al. Fibrin glue effectiveness and tolerance after elective liver resection: a randomized trial. Hepatogastroenterology 1996; 43: 221–4.
32. Poon RT et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases. Analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004; 240 (4): 698–708.
33. Schindl MJ et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289–96.
34. Schuman R et al. Altered hematologic profiles following donor right hepatectomy and implications for perioperative analgesic management. Liver Transpl 2004; 10 (3): 363–8.
35. Scwartz M et al. Comparison of new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004; 139: 1148–54.
36. Sierra DH. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J Biomater Appl 1993; 7: 309–52.
37. Simmonds PC et al. Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer 2006; 94: 982–99.
38. Thompson HH et al. Major hepatic resection. A 25-year experience. Ann Surg 1983; 197 (4): 375–88.
39. Tredwell S et al. Use of fibrin sealants for localized, controlled release of cefasolin. Can J Surg 2006; 49 (5): 347–52.

Н.Н.Багмет, Н.К.Чардаров, О.Г.Скипенко

Учреждение Российской академии медицинских наук
Российский научный центр хирургии им. акад. Б.В.Петровского РАМН, Москва